An Investigator Initiated Study for OTOV101N+OTOV101C Injection

NCT05901480 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

DFNB9

Interventions

GENETIC: OTOV101N+OTOV101C Injections

Sponsor

Otovia Therapeutics